Supplemental Tables from 14-3-3σ Contributes to Radioresistance by Regulating DNA Repair and Cell Cycle Via PARP1 and CHK2

Yifan Chen,Zhaomin Li,Dong Zhao,Jenny Beebe,Ke Yang,Liwu Fu,Jian‐Ting Zhang

DOI: https://doi.org/10.1158/1541-7786.22515373

2023-01-01

Abstract:Supplemental Table S1. Sequence of shRNAs and siRNAs. Supplemental Table S2. Sequences of primers for real time RT-PCR.

What problem does this paper attempt to address?

Supplemental Tables from 14-3-3σ Contributes to Radioresistance by Regulating DNA Repair and Cell Cycle Via PARP1 and CHK2

Yifan Chen,Zhaomin Li,Dong Zhao,Jenny Beebe,Ke Yang,Liwu Fu,Jian‐Ting Zhang

DOI: https://doi.org/10.1158/1541-7786.22515373.v1

2023-01-01

Abstract:Supplemental Table S1. Sequence of shRNAs and siRNAs. Supplemental Table S2. Sequences of primers for real time RT-PCR.
Supplementary Table S1 from Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung Cancer

Yuning Liu,Qingzhe Wu,Bin Jiang,Tingting Hou,Chuanqiang Wu,Ming Wu,Hai Song

DOI: https://doi.org/10.1158/1541-7786.26144994

2024-01-01

Abstract:Supplementary Table S1. Sequences for sgRNA, shRNA or siRNA.
Supplemental Figures 1-7 from 14-3-3σ Contributes to Radioresistance by Regulating DNA Repair and Cell Cycle Via PARP1 and CHK2

Yifan Chen,Zhaomin Li,Dong Zhao,Jenny Beebe,Ke Yang,Liwu Fu,Jian‐Ting Zhang

DOI: https://doi.org/10.1158/1541-7786.22515376

2023-01-01

Abstract:Figure S1. 14-3-3Ïƒ contributes to IR resistance. Figure S2. 14-3-3Ïƒ contributes to IR resistance in H1299 cells. Figure S3. 14-3-3Ïƒ modulates IR-induced Î³-H2AX in H1299 cells. Figure S4. 14-3-3Ïƒ promotes NHEJ but not HR repair of DSBs. Figure S5. Role of PARP1 in DNA-PKcs recruitment. Figure S6. 14-3-3Ïƒ regulation of Chk2 expression in H1299 cells. Figure S7. PARP1 regulates Chk2 expression but not vice versa.
Supplementary Table 1 from Survivin Expression Is Differentially Regulated by a Selective Cross-talk between RBM38 and miRNAs let-7b or miR-203a

Christopher A. Lucchesi,Jin Zhang,Buyong Ma,Ruth Nussinov,Xinbin Chen

DOI: https://doi.org/10.1158/0008-5472.22428423.v1

2023-01-01

Abstract:List of all the primers used in the study
Supplementary Primers and Shrna Information from DDR2 Coordinates EMT and Metabolic Reprogramming As a Shared Effector of FOXQ1 and SNAI1

Allison V. Mitchell,Jason Wu,Fanliang Meng,Dong Li,C. James Block,Won‐Min Song,Bin Zhang,Jing Li,Guojun Wu

DOI: https://doi.org/10.1158/2767-9764.22545699

2023-01-01

Abstract:Information of PCR primers for all gene tested and information for shRNA sequences for targeting several genes.
Supplementary Tables 1-4 from Targeting FBW7 As a Strategy to Overcome Resistance to Targeted Therapy in Non–Small Cell Lung Cancer

Mingxiang Ye,Yong Zhang,Xinxin Zhang,Jianbin Zhang,Pengyu Jing,Liang Cao,Nan Li,Xia Li,Libo Yao,Jian Zhang

DOI: https://doi.org/10.1158/0008-5472.22413117

2023-01-01

Abstract:This supplementary tables contain shRNAs, siRNAs, primers sequences and antibody resources.
Supplementary Table S1 from Germline Mutations of Holliday Junction Resolvase Genes in Multiple Primary Malignancies Involving Lung Cancer Lead to PARP Inhibitor Sensitization

Haoran Wang,Yuping Chen,Xinshu Wang,Binhao Huang,Juntao Xie,Hui Yin,Jie Yang,Jinhuan Wu,Jian Yuan,Jie Zhang

DOI: https://doi.org/10.1158/1078-0432.25603569.v1

2024-01-01

Abstract:Supplementary Table S1: The gene list for pathway enrichment analysis.
Supplementary Table S1 from PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models

Ariel L. Hernandez,Christian D. Young,Li Bian,Kelsey Weigel,Kyle Nolan,Barbara Frederick,Gangwen Han,Guanting He,G. Devon Trahan,Michael C. Rudolph,Kenneth Lyons Jones,Ayman Oweida,Sana D. Karam,David Raben,Xiao‐Jing Wang

DOI: https://doi.org/10.1158/1078-0432.22473926.v1

2023-01-01

Abstract:Supplementary Table S1 lists reagents used
Supplementary Table S4. from MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative Breast Cancer

Si Min Zheng,Yu Chen Feng,Qin Zhu,Ruo Qi Li,Qian Qian Yan,Liu Teng,Yi Meng Yue,Man Man Han,Kaihong Ye,Sheng Nan Zhang,Teng Fei Qi,Cai Xia Tang,Xiao Hong Zhao,Yuan Yuan Zhang,Liang Xu,Ran Xu,Jun Xing,Mark Baker,Tao Liu,Rick F. Thorne,Lei Jin,Thomas Preiss,Xu Dong Zhang,Shundong Cang,Jin Nan Gao

DOI: https://doi.org/10.1158/0008-5472.25735719.v1

2024-01-01

Abstract:<p>List of siRNAs/shRNAs.</p>
Supplementary Table 1 from Valosin-Containing Protein Stabilizes Mutant P53 to Promote Pancreatic Cancer Growth

Jieqiong Wang,Yajie Chen,Canhua Huang,Quan Hao,Shelya X. Zeng,Sara Omari,Yu Zhang,Xiang Zhang,Hua Liu

DOI: https://doi.org/10.1158/0008-5472.22428753.v1

2023-01-01

Abstract:Supplementary Table S1 shows the sequences of siRNAs and the targeting sequences of high scored sgRNAs for CRISPR/Cas9.
Supplementary Table from Decreased DNA Damage and Improved P53 Specificity of RITA Analogs

Yue Zhan,Xiaolei Zhou,Sylvain Peuget,Madhurendra Singh,Brian D. Peyser,Zhimin Fan,Galina Selivanova

DOI: https://doi.org/10.1158/1535-7163.22523830.v1

2023-01-01

Abstract:Supplementary Table from Decreased DNA Damage and Improved p53 Specificity of RITA Analogs
Supplementary Table S1 from Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1–MAPK Interaction

Xin Jin,Yunqian Pan,Liguo Wang,Tao Ma,Lizhi Zhang,Amy H. Tang,Daniel D. Billadeau,Heshui Wu,Haojie Huang

DOI: https://doi.org/10.1158/0008-5472.22414158.v1

2023-01-01

Abstract:Sequences for primers used for shRNAs and RT-qPCR
Supplementary Tables from NAT10 Drives Cisplatin Chemoresistance by Enhancing Ac4c-Associated DNA Repair in Bladder Cancer

Ruihui Xie,Liang Cheng,Ming Huang,Lin Huang,Ziyue Chen,Qiang Zhang,Hong Li,Junlin Lu,Hongjin Wang,Qianghua Zhou,Jian Huang,Xu Chen,Tianxin Lin

DOI: https://doi.org/10.1158/0008-5472.22746970.v1

2023-01-01

Abstract:Supplementary Materials and Methods
Supplementary Table 4 from ATR Inhibition is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer

Xinyi Tu,Mohamed M. Kahila,Qin Zhou,Jia Yu,Krishna R. Kalari,Liewei Wang,William S. Harmsen,Jian Yuan,Judy C. Boughey,Matthew P. Goetz,Jann N. Sarkaria,Zhenkun Lou,Robert W. Mutter

DOI: https://doi.org/10.1158/1535-7163.22504606

2023-01-01

Abstract:Supplementary Table 4 demonstrates single nucleotide variants, indels, copy number variants and copy number alterations in MCTNBC4
Supplementary Table S5. from MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative Breast Cancer

Si Min Zheng,Yu Chen Feng,Qin Zhu,Ruo Qi Li,Qian Qian Yan,Liu Teng,Yi Meng Yue,Man Man Han,Kaihong Ye,Sheng Nan Zhang,Teng Fei Qi,Cai Xia Tang,Xiao Hong Zhao,Yuan Yuan Zhang,Liang Xu,Ran Xu,Jun Xing,Mark Baker,Tao Liu,Rick F. Thorne,Lei Jin,Thomas Preiss,Xu Dong Zhang,Shundong Cang,Jin Nan Gao

DOI: https://doi.org/10.1158/0008-5472.25735716

2024-01-01

Abstract:<p>List of primers, probes and adaptors.</p>
Supplementary Table I and II from PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer

Nisha Nagarsheth,Dongjun Peng,Ilona Kryczek,Ke Wu,Wei Li,Ende Zhao,Lili Zhao,Shuang Wei,Timothy Frankel,Linda Vatan,Wojciech Szeliga,Yali Dou,Scott Owens,Victor Marquez,Kaixiong Tao,Emina Huang,Guobin Wang,Weiping Zou

DOI: https://doi.org/10.1158/0008-5472.22409408.v1

2023-01-01

Abstract:This is Supplementary Tables I and II Table 1: RT-PCR primers and ChIP primers Table 2: shRNA Sequences
Supplementary Table S3. Primers and siRNAs from SPARC Stabilizes ApoE to Induce Cholesterol-Dependent Invasion and Sorafenib Resistance in Hepatocellular Carcinoma

Shan Wan,Quan-Yao He,Yun Yang,Feng Liu,Xue Zhang,Xin Guo,Hui Niu,Yi Wang,Yi-Xuan Liu,Wen-Long Ye,Xiu-Ming Li,Xue-Mei ZhuanSun,Pu Sun,Xiao-Shun He,Guang Hu,Kai Breuhahn,Hua Zhao,Guo-Qiang Wu,Hua Wu

DOI: https://doi.org/10.1158/0008-5472.25964444.v1

2024-01-01

Abstract:Supplementary Table S3. Primers and siRNAs
Supplementary Tables 1-5 from A Small Interfering RNA Screen of Genes Involved in DNA Repair Identifies Tumor-Specific Radiosensitization by POLQ Knockdown

Geoff S. Higgins,Remko Prevo,Yin-Fai Lee,Thomas Helleday,Ruth J. Muschel,Steve Taylor,Michio Yoshimura,Ian D. Hickson,Eric J. Bernhard,W. Gillies McKenna

DOI: https://doi.org/10.1158/0008-5472.22386911

2023-01-01

Abstract:Supplementary Tables 1-5 from A Small Interfering RNA Screen of Genes Involved in DNA Repair Identifies Tumor-Specific Radiosensitization by POLQ Knockdown
Supplementary Tables 8 - 9 from LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act As a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern

Tian-Tian Sun,Jie He,Qian Liang,Lin-Lin Ren,Ting-Ting Yan,Ta-Chung Yu,Jia-Yin Tang,Yu-Jie Bao,Ye Hu,Yanwei Lin,Danfeng Sun,Ying-Xuan Chen,Jie Hong,Haoyan Chen,Weiping Zou,Jing-Yuan Fang

DOI: https://doi.org/10.1158/2159-8290.22531628.v1

2023-01-01

Abstract:Supplementary Table 8. Sequence of primers for real-time PCR. Supplementary Table 9. Sequence of primers for CHIP real-time PCR.
Supplementary Table S2 from Mutant P53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones

Yi Ren,Lisa K. Mullany,Zhilin Liu,Alan J. Herron,Kwong-Kwok Wong,JoAnne S. Richards

DOI: https://doi.org/10.1158/0008-5472.22411352.v1

2023-01-01

Abstract:Real-time PCR primer set sequences.

Supplemental Tables from 14-3-3σ Contributes to Radioresistance by Regulating DNA Repair and Cell Cycle Via PARP1 and CHK2

Supplemental Tables from 14-3-3σ Contributes to Radioresistance by Regulating DNA Repair and Cell Cycle Via PARP1 and CHK2

Supplementary Table S1 from Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung Cancer

Supplemental Figures 1-7 from 14-3-3σ Contributes to Radioresistance by Regulating DNA Repair and Cell Cycle Via PARP1 and CHK2

Supplementary Table 1 from Survivin Expression Is Differentially Regulated by a Selective Cross-talk between RBM38 and miRNAs let-7b or miR-203a

Supplementary Primers and Shrna Information from DDR2 Coordinates EMT and Metabolic Reprogramming As a Shared Effector of FOXQ1 and SNAI1

Supplementary Tables 1-4 from Targeting FBW7 As a Strategy to Overcome Resistance to Targeted Therapy in Non–Small Cell Lung Cancer

Supplementary Table S1 from Germline Mutations of Holliday Junction Resolvase Genes in Multiple Primary Malignancies Involving Lung Cancer Lead to PARP Inhibitor Sensitization

Supplementary Table S1 from PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models

Supplementary Table S4. from MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative Breast Cancer

Supplementary Table 1 from Valosin-Containing Protein Stabilizes Mutant P53 to Promote Pancreatic Cancer Growth

Supplementary Table from Decreased DNA Damage and Improved P53 Specificity of RITA Analogs

Supplementary Table S1 from Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1–MAPK Interaction

Supplementary Tables from NAT10 Drives Cisplatin Chemoresistance by Enhancing Ac4c-Associated DNA Repair in Bladder Cancer

Supplementary Table 4 from ATR Inhibition is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer

Supplementary Table S5. from MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative Breast Cancer

Supplementary Table I and II from PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer

Supplementary Table S3. Primers and siRNAs from SPARC Stabilizes ApoE to Induce Cholesterol-Dependent Invasion and Sorafenib Resistance in Hepatocellular Carcinoma

Supplementary Tables 1-5 from A Small Interfering RNA Screen of Genes Involved in DNA Repair Identifies Tumor-Specific Radiosensitization by POLQ Knockdown

Supplementary Tables 8 - 9 from LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act As a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern

Supplementary Table S2 from Mutant P53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones